For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

ROUNDTABLE APAC 1 - Maximizing CGT product value: Why you shouldn’t overlook APAC
Saturday, June 3, 2023 09:00 AM - 10:00 AM  
Room 251
APAC
Roundtable
How to navigate the complex APAC market to create a sound global commercialization strategy
​
Moderator
Karolis Rosickas, BSc, MBA, CEO, Regeneus Ltd, Singapore

Panelists
Kunihiko Suzuki, MBA, MEDINET Co., Ltd., Japan
William Yong Khee Hwang, MBBS, MMed, MRCP, FAMS, FRCP, CEO and Professor, National Cancer Centre Singapore and Duke-NUS Medical School, Singapore
Rajiv Khanna, PhD, Director, QIMR Centre for Immunotherapy and Vaccine Development, Australia
Anthony Ting, PhD, Program Leader, Oncology Cell Therapy Innovation, Takeda, USA 

Learning Objectives
  1. Recognize the significance of the APAC region and the opportunity for earlier market approvals to your overall global product program value.
  2. Understand the key considerations for establishing an APAC Strategy to be compliant for both intra-APAC INDs and approvals as well as compliance for regulatory submissions from the US and EU.
  3. Consider how your APAC Strategy impacts partnering: both in-licensing and out-licensing for global development and commercialization.
Karolis Rosickas BSc, MBA
Chief Executive Officer
 Regeneus Ltd
 Moderator
WILLIAM YING KHEE HWANG
CEO and Professor
 National Cancer Centre Singapore and Duke-NUS Medical School
 Panelist
Rajiv Khanna PhD, AO FAHMS
Co-Director, Queensland Immunology Research Centre
QIMR Centre for Immunotherapy and Vaccine Development
 Panelist
Kunihiko Suzuki MBA
MEDINET Co., Ltd
 Panelist
Anthony Ting
Principal
 BRL CGT Consulting, LLC
 Panelist